Compare AFG & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AFG | RDY |
|---|---|---|
| Founded | 1872 | 1984 |
| Country | United States | India |
| Employees | 8500 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 11.8B |
| IPO Year | N/A | 2001 |
| Metric | AFG | RDY |
|---|---|---|
| Price | $143.43 | $11.81 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $141.00 | $16.90 |
| AVG Volume (30 Days) | 385.2K | ★ 3.1M |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.72% | 0.52% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.72 |
| Revenue Next Year | $4.44 | $3.50 |
| P/E Ratio | ★ $12.86 | $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $122.11 | $11.36 |
| 52 Week High | $150.02 | $15.67 |
| Indicator | AFG | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 59.56 | 32.74 |
| Support Level | $128.04 | N/A |
| Resistance Level | $144.74 | $13.96 |
| Average True Range (ATR) | 2.52 | 0.39 |
| MACD | -0.22 | -0.21 |
| Stochastic Oscillator | 73.51 | 15.77 |
American Financial Group Inc is an insurance holding company. Through its subsidiaries, it is engaged in the property and casualty insurance business, focusing on specialized commercial products for businesses. The group operates through two segments: Property and Casualty Insurance, which generates maximum revenue, and Other. The Property and Casualty Insurance segment is further divided into different sub-segments, such as Property and transportation, Specialty casualty, and Specialty financial. These sub-segments offer insurance coverage for vehicles and commercial property, customized programs for small to mid-sized businesses, workers' compensation insurance, risk management insurance programs for lending and leasing institutions, trade credit insurance, and other insurance products.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.